Why Baby Bunting, Carsales, GWA, and Imugene shares are racing higher

These ASX shares are starting the week strongly.

| More on:
An investor sits at her desk and stretches her arms above her head in delight.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is currently down 0.9% to 7,272.1 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price is up 9% to $2.28. Investors have been buying this baby products retailer's shares after analysts at Morgans upgraded them to an add rating with a $2.50 price target. The broker made the move after increasing its earnings estimates to reflect cost reductions and a better sales outlook.

Carsales.Com Ltd (ASX: CAR)

The Carsales share price is up 6% to $26.11. This follows the release of the auto listings company's FY 2023 results. Carsales reported an 18% increase in pro forma revenue and a 43% lift in adjusted net profit after tax to $278.2 million. Looking ahead, management expects "to deliver good growth in Revenue and [pro forma] EBITDA in FY24" and an "expansion in the carsales Group EBITDA margin."

GWA Group Ltd (ASX: GWA)

The GWA share price is up 7% to $2.06. This has been driven by the release of the building fittings company's full-year results. GWA reported a 22.7% increase in statutory net profit to $43.2 million. Management commented: "GWA delivered a solid result for FY23 within a rapidly evolving operating environment that comprised two distinct halves."

Imugene Limited (ASX: IMU)

The Imugene share price is up 3.5% to 9.2 cents. This morning, this immuno-oncology company announced that its Phase 1 MAST (metastatic advanced solid tumours) trial evaluating the safety of novel cancer-killing virus CF33- hNIS (VAXINIA) has cleared the cohort 3 intratumoral (IT) arm of the monotherapy dose escalation study.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Carsales.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »